Cipla Ltd.

NSE: CIPLA · Healthcare

₹1,411.00+0.49%06 Nov 2026

Ask the data

Instant answers about Cipla Ltd. — computed from its filings, no language model

Market cap₹1,13,988 cr

Current price₹1,411.00

High / Low₹1,540 / ₹1,192

P/E39.3

P/B3.22

Book value₹438.1

ROE8.2%

ROCE11.0%

Debt / equity0.01

Dividend yield1.13%

EPS (TTM)₹35.86

Face value₹2

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 9 periods

	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	15,219	16,362	17,132	19,160	21,763	22,753	25,774	27,548	28,163
EBITDA	2,826	3,097	3,206	4,252	4,553	5,027	6,291	7,128	5,883
Operating margin	18.6%	18.9%	18.7%	22.2%	20.9%	22.1%	24.4%	25.9%	20.9%
Interest	114	168	197	161	106	110	90	62	54
Depreciation	1,323	1,326	1,175	1,068	1,052	1,172	1,051	1,107	1,211
Profit before tax	1,669	2,079	2,178	3,290	3,493	4,038	5,702	6,821	5,224
Tax	250	570	631	889	934	1,203	1,547	1,530	1,354
Net profit	1,411	1,528	1,547	2,405	2,517	2,802	4,122	5,273	3,879
EPS ₹	17.53	18.97	19.19	29.82	31.20	34.72	51.05	65.29	48.03
Operating cash flow	—	—	—	—	3,326	3,238	4,134	5,005	3,940
Capex	—	—	—	—	701	1,183	1,349	1,548	3,079
Dividend paid	—	—	—	—	403	404	686	1,050	1,292
Total assets	22,861	23,963	23,663	25,152	27,101	29,463	32,718	37,387	42,496
Equity	14,229	15,012	15,763	18,327	20,842	23,408	26,706	31,193	34,432

Quarterly performance

last 34 quarters · ₹ crore

showing latest 8 of 34 periods

	MAR '18	JUN '18	SEP '18	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	3,698	3,939	4,012	4,008	4,404	3,989	4,396	4,371	4,376	4,346	5,038	5,169	4,606	5,504	5,520	5,479	5,260	5,829	5,810	5,739	6,329	6,678	6,604	6,163	6,694	7,051	7,073	6,730	6,957	7,589	7,074	6,541	7,119	7,404
Operating profit	557	726	702	708	961	905	910	758	634	1,049	1,177	1,231	796	1,346	1,226	1,231	750	1,302	1,408	1,174	1,494	1,734	1,748	1,316	1,716	1,886	1,989	1,538	1,778	1,895	1,255	955	1,192	1,388
Operating margin	15.1%	18.4%	17.5%	17.7%	21.8%	22.7%	20.7%	17.3%	14.5%	24.1%	23.4%	23.8%	17.3%	24.5%	22.2%	22.5%	14.3%	22.3%	24.2%	20.5%	23.6%	26.0%	26.5%	21.4%	25.6%	26.7%	28.1%	22.8%	25.6%	25.0%	17.7%	14.6%	16.7%	18.7%
Other income	40	170	133	79	95	78	101	72	93	65	53	87	60	65	61	91	64	123	114	135	136	176	185	249	160	191	222	289	259	269	206	148	211	151
Interest	35	35	44	44	45	52	46	46	53	46	39	48	27	30	38	21	18	26	32	34	16	26	30	18	18	15	15	14	14	13	14	13	17	17
Depreciation	285	241	282	293	510	268	283	278	346	269	265	248	285	261	253	247	290	299	272	346	239	290	233	288	247	272	280	309	253	297	278	383	304	345
Profit before tax	199	620	509	449	501	663	681	506	328	799	926	1,021	544	996	996	1,054	448	1,100	1,218	745	1,375	1,594	1,474	1,259	1,611	1,789	1,916	1,504	1,770	1,854	893	707	1,082	1,177
Tax	46	174	142	126	128	192	201	153	86	228	264	269	128	284	284	295	71	303	410	222	378	438	405	325	435	483	332	279	478	500	219	157	295	321
Net profit	179	451	377	322	367	478	471	351	246	578	665	748	413	715	711	729	362	789	801	526	996	1,131	1,056	939	1,178	1,303	1,571	1,222	1,298	1,351	676	555	789	878
EPS ₹	2.22	5.60	4.68	4.12	4.56	5.93	5.85	4.35	3.05	7.17	8.25	9.28	5.13	8.86	8.82	9.03	4.49	9.78	9.92	6.51	12.34	14.01	13.08	11.63	14.58	16.13	19.45	15.13	16.07	16.73	8.37	6.87	9.77	10.86
Revenue YoY	—	—	—	—	19.1%	1.3%	9.6%	9.1%	-0.6%	9.0%	14.6%	18.2%	5.3%	26.6%	9.6%	6.0%	14.2%	5.6%	6.0%	9.1%	—	14.6%	13.7%	7.4%	5.8%	5.6%	7.1%	9.2%	3.9%	7.6%	0.0%	-2.8%	2.3%	-2.4%
Profit YoY	—	—	—	—	105.6%	6.0%	25.0%	8.9%	-33.0%	20.9%	41.2%	113.1%	68.1%	23.7%	6.9%	-2.6%	-12.4%	10.9%	9.9%	45.2%	—	43.4%	31.8%	78.6%	18.3%	15.2%	48.7%	30.1%	10.2%	3.7%	-57.0%	-54.6%	-39.2%	-35.1%

Earlier results (standalone, Sep '07 – Dec '17)

₹ crore · from BSE, before the NSE XBRL filings begin

Cipla Ltd. reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 9 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†
Revenue	5,271	5,632	6,318	6,993	8,187	9,380	10,132	12,034	10,925
Operating profit	1,051	1,360	1,337	1,597	2,119	1,990	1,961	2,054	1,587
Operating margin	19.9%	24.2%	21.2%	22.8%	25.9%	21.2%	19.4%	17.1%	14.5%
Other income	68	88	79	118	229	280	148	259	139
Interest	34	24	5	12	33	128	136	133	39
Depreciation	176	189	254	282	303	324	433	441	500
Profit before tax	910	1,331	1,158	1,349	2,012	1,818	1,540	1,740	1,187
Tax	142	248	191	225	505	430	359	342	212
Net profit	768	1,082	967	1,124	1,507	1,388	1,181	1,398	975

Quarters

showing latest 8 of 42 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†
Revenue	1,098	1,104	1,122	1,207	1,355	1,342	1,367	1,376	1,443	1,438	1,375	1,480	1,615	1,554	1,669	1,591	1,778	1,758	1,866	1,958	2,192	2,070	1,967	2,464	2,347	2,282	2,287	2,474	2,490	2,466	2,701	3,542	3,073	2,678	2,741	2,741	2,814	2,675	2,695	2,684	3,065	2,970
Operating profit	224	262	203	195	211	296	349	342	381	380	258	351	367	318	302	370	438	391	399	540	677	493	409	675	553	403	358	533	554	482	393	935	685	329	105	420	452	532	183	417	675	679
Operating margin	20.4%	23.7%	18.1%	16.2%	15.6%	22.0%	25.5%	24.8%	26.4%	26.4%	18.8%	23.7%	22.7%	20.5%	18.1%	23.2%	24.6%	22.3%	21.4%	27.6%	30.9%	23.8%	20.8%	27.4%	23.6%	17.7%	15.7%	21.5%	22.2%	19.5%	14.6%	26.4%	22.3%	12.3%	3.8%	15.3%	16.1%	19.9%	6.8%	15.5%	22.0%	22.9%
Other income	42	24	41	17	17	18	15	12	13	18	45	17	17	26	20	25	24	30	39	53	64	53	58	69	65	53	94	37	23	47	41	108	30	69	52	31	33	45	31	51	180	41
Interest	2	4	5	4	6	11	13	10	8	4	0	0	0	3	2	4	2	3	2	1	5	9	18	41	34	28	25	25	32	43	36	43	45	18	26	13	7	15	4	1	5	2
Depreciation	33	33	37	38	41	41	56	46	48	46	49	55	64	65	70	70	66	76	70	73	74	78	78	79	82	82	81	114	110	98	111	106	108	112	115	111	129	135	125	126	133	138
Profit before tax	231	250	202	171	182	262	296	297	337	348	348	312	319	276	251	320	394	270	365	519	662	459	372	625	502	346	346	430	435	387	287	894	562	268	16	328	349	426	84	341	718	581
Tax	40	39	23	30	30	39	43	56	62	59	73	55	56	43	37	67	85	0	73	118	162	120	104	150	126	85	69	98	99	88	73	204	154	2	-19	49	20	85	58	82	152	162
Net profit	191	211	179	140	151	223	253	242	276	289	276	257	263	233	214	253	309	270	292	401	500	339	268	475	376	261	277	332	336	299	214	690	407	266	35	279	329	341	26	259	566	419
EPS ₹	2.45	2.71	2.30	1.80	1.95	2.87	3.25	3.11	3.55	3.60	3.43	3.21	3.27	2.90	2.67	3.16	3.85	3.37	3.63	4.99	6.23	4.22	3.33	5.91	4.68	3.25	3.44	4.14	4.18	3.72	2.66	8.59	5.08	3.31	0.43	3.47	4.10	4.25	0.32	3.22	7.03	5.20
Revenue YoY	—	—	—	—	23.3%	21.5%	21.8%	14.0%	6.5%	7.2%	0.6%	7.5%	12.0%	8.0%	21.4%	7.5%	10.1%	13.2%	11.8%	23.0%	23.3%	17.8%	5.4%	25.8%	7.1%	10.2%	16.3%	0.4%	6.1%	8.1%	18.1%	43.2%	23.4%	8.6%	1.5%	-22.6%	-8.4%	-0.1%	-1.7%	-2.1%	8.9%	11.0%
Profit YoY	—	—	—	—	-20.6%	6.1%	40.9%	72.6%	82.1%	29.4%	8.9%	6.5%	-4.6%	-19.5%	-22.3%	-1.6%	17.5%	16.0%	36.3%	58.2%	61.8%	25.5%	-8.3%	18.5%	-24.8%	-23.0%	3.4%	-30.1%	-10.6%	14.6%	-22.7%	107.7%	21.2%	-11.0%	-83.8%	-59.6%	-19.2%	28.3%	-25.3%	-7.1%	72.0%	22.7%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 28 periods

	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	9.3%	10.1%	10.3%	10.9%	11.1%	9.8%	10.4%	11.7%	14.2%	13.1%	13.9%	14.1%	14.0%	12.1%	13.3%	13.9%	14.9%	15.4%	16.1%	15.8%	17.6%	16.9%	17.3%	16.5%	13.8%	11.3%	9.8%	8.2%
ROCE	10.6%	11.6%	11.9%	12.8%	13.1%	12.8%	13.5%	14.8%	17.5%	17.2%	18.1%	18.4%	18.4%	16.6%	19.0%	19.8%	20.8%	21.5%	22.4%	21.8%	23.3%	22.0%	22.5%	21.5%	18.4%	15.2%	13.2%	11.0%
Net margin	8.5%	9.3%	9.4%	9.8%	9.7%	9.0%	9.4%	10.1%	11.8%	12.6%	12.5%	12.4%	12.2%	11.6%	13.1%	14.1%	14.6%	16.0%	16.5%	16.9%	18.5%	19.1%	19.4%	19.2%	16.0%	13.8%	11.9%	10.3%
EBITDA margin	17.2%	18.9%	20.0%	20.7%	20.6%	18.7%	19.2%	19.9%	21.6%	22.2%	22.4%	22.1%	21.8%	20.9%	22.7%	23.7%	24.3%	24.4%	24.9%	25.1%	25.6%	25.9%	25.9%	25.4%	22.8%	20.9%	18.7%	17.0%
Debt / equity	0.29	0.29	0.29	0.29	0.29	0.18	0.18	0.18	0.18	0.10	0.10	0.10	0.10	0.04	0.02	0.03	0.03	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.01	0.01	0.01
Interest coverage	12.19	13.34	12.44	13.26	13.43	12.04	13.10	14.87	17.51	21.47	25.17	25.88	32.02	33.85	42.05	46.51	49.65	64.44	65.95	76.68	101.27	111.00	121.11	127.03	109.92	97.04	80.06	64.34
Asset turnover	0.68	0.68	0.68	0.70	0.72	0.72	0.74	0.77	0.80	0.76	0.81	0.83	0.84	0.80	0.80	0.78	0.81	0.79	0.80	0.77	0.78	0.74	0.74	0.71	0.71	0.66	0.67	0.65

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 16 periods

	MAR '16‡	MAR '17‡	MAR '18‡	MAR '19‡	MAR '20‡	MAR '21‡	MAR '22‡	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	161	161	161	161	161	161	161	161	161	161	161	162	162	162	162	162
Other equity / reserves	11,356	12,383	14,068	14,851	15,602	18,165	20,680	21,723	23,246	24,664	26,545	28,201	31,032	32,757	34,270	35,234
Total equity	11,516	12,544	14,229	15,012	15,763	18,327	20,842	21,884	23,408	24,825	26,706	28,362	31,193	32,919	34,432	35,396
Borrowings	5,192	4,113	4,098	4,316	2,816	1,756	824	853	520	674	247	162	92	94	258	267
Current liabilities	7,776	—	3,832	3,772	4,393	4,591	4,913	5,309	5,033	5,559	5,246	5,455	5,484	6,297	7,014	6,977
Non-current liabilities	1,486	—	4,447	4,848	3,212	1,975	1,071	584	640	633	670	745	614	842	962	935
Total assets	21,128	21,037	22,861	23,963	23,663	25,152	27,101	28,063	29,463	31,377	32,718	34,655	37,387	40,164	42,496	43,434
Property, plant & equipment	4,605	5,009	5,315	5,114	4,805	4,618	4,839	5,080	4,991	4,819	5,069	5,119	5,262	5,503	6,040	6,555
Capital work-in-progress	741	719	512	331	421	571	383	510	689	791	864	1,097	1,213	1,437	1,586	1,711
Investments	758	973	1,259	2,554	1,471	2,710	2,551	2,796	3,662	4,272	5,449	4,995	7,933	8,219	8,223	6,686
Inventories	3,808	3,485	4,045	3,965	4,378	4,669	5,350	5,441	5,156	5,470	5,238	5,573	5,642	6,160	6,597	6,778
Receivables	2,356	2,563	3,102	4,151	3,891	3,446	3,424	3,969	4,057	4,850	4,771	5,588	5,506	6,902	5,620	6,000
Cash & equivalents	858	610	853	508	742	793	678	687	628	800	640	798	589	762	1,018	1,659

Cash flow

annual · ₹ crore · line = free cash flow

showing latest 5 of 11 periods

	FY16‡	FY17‡	FY18‡	FY19‡	FY20‡	FY21‡	FY22	FY23	FY24	FY25	FY26
Cash from operations	1,741	2,382	1,463	1,691	3,068	3,755	3,326	3,238	4,134	5,005	3,940
Cash from investing	-4,523	-1,310	-854	-1,669	104	-2,387	-1,872	-2,389	-2,988	-3,691	-2,326
Cash from financing	3,104	-1,326	-385	-349	-2,949	-1,240	-1,600	-958	-1,200	-1,293	-1,234
Capex	1,077	1,136	816	527	1,000	819	701	1,183	1,349	1,548	3,079
Free cash flow	664	1,246	647	1,164	2,068	2,936	2,625	2,055	2,785	3,457	861
Dividends paid	161	161	161	242	564	0	403	404	686	1,050	1,292

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹6,555 cr15%

CWIP

₹1,711 cr4%

Investments

₹6,686 cr15%

Inventories

₹6,778 cr16%

Receivables

₹6,000 cr14%

Cash & equivalents

₹1,659 cr4%

Other assets

₹14,045 cr32%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%

StoxGud checklist: Neutral setup · 6/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+6.3%

6 months+3.6%

1 year-10.8%

3Y CAGR+5.4%

5Y CAGR+9.1%

10Y CAGR+10.0%

50-day avg₹1,367.44

200-day avg₹1,363.66

RSI (14)82

Long-term financials (FY12–FY12)

from published annual reports

Year	Revenue	Profit before tax	Net profit
FY12	₹7,021 Cr	₹1,448 Cr	₹1,144 Cr

Years before FY17 follow the older Indian GAAP standard, so they are not exactly comparable with recent years.

Compare Cipla Ltd. with

Laurus Labs vs Cipla Apollo Hospitals Enterprise vs Cipla Zydus Lifesciences vs Cipla Dr. Reddy's Laboratories vs Cipla Cipla vs Mankind Pharma Cipla vs Aurobindo Pharma

FAQs

What is the share price of Cipla Ltd.?

Cipla Ltd. (CIPLA) closed at ₹1,411.00 on NSE on 06 Nov 2026.

What is the market cap of Cipla Ltd.?

₹1,13,988 crore at the latest close.

What is the P/E ratio of Cipla Ltd.?

39.3, on trailing-twelve-month earnings from its filings.

How fast is Cipla Ltd. growing?

Cipla Ltd.: revenue has compounded at 7.4% a year over three years; net profit at 11.5% a year. Latest-quarter revenue is down 2.4% year on year, profit down 35.1%.

How profitable is Cipla Ltd.?

On a trailing-twelve-month basis return on equity is 8.2%, return on capital employed 11.0%, operating margin 17.0%, net margin 10.3%.

How much debt does Cipla Ltd. have?

Cipla Ltd. is debt-free: debt to equity is 0.01 with borrowings of ₹267 cr against cash of ₹1,659 cr (balance sheet of 2026-09-30). Operating profit covers interest 64.3 times.

Financials parsed from Cipla Ltd.'s own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '18, annual from FY18, balance sheet from Mar '16. * = derived (full year or half year minus earlier quarters). ‡ = balance sheet / cash flow read from the company's published annual report (same basis), for years before the NSE filings carry them; each one checked to add up. Information only, not investment advice.